Geron Corporation (GERN)

US — Healthcare Sector
Peers:   VKTX  TGTX  XFOR  PDSB  MDGL  ZURA  ENVB  EFTR  IMMX  ELEV  SRPT  HEPA  PTCT  CWBR  OCEA  AVRO 

Automate Your Wheel Strategy on GERN

With Tiblio's Option Bot, you can configure your own wheel strategy including GERN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol GERN
  • Rev/Share 0.1746
  • Book/Share 0.4028
  • PB 3.8727
  • Debt/Equity 0.454
  • CurrentRatio 7.8651
  • ROIC -0.2679

 

  • MktCap 993592080.0
  • FreeCF/Share -0.307
  • PFCF -4.8608
  • PE -7.4726
  • Debt/Assets 0.2165
  • DivYield 0
  • ROE -0.4846

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 2
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade GERN Scotiabank Sector Outperform Sector Perform -- $1.5 May 8, 2025
Downgrade GERN B. Riley Securities Buy Neutral $3.5 $2 Feb. 27, 2025
Downgrade GERN H.C. Wainwright Buy Neutral -- -- Feb. 26, 2025
Initiation GERN Scotiabank -- Sector Outperform -- -- Oct. 16, 2024
Initiation GERN Leerink Partners -- Outperform -- $7 Sept. 9, 2024

News

GERON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Geron Corporation and Encourages Investors to Contact the Firm
GERN
Published: March 19, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Geron securities between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”). Investors have until May 12, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read More
image for news GERON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Geron Corporation and Encourages Investors to Contact the Firm
Investors in Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN
GERN
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=137298&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors in Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN
ROSEN, A LEADING LAW FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN
GERN
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Geron Corporation (NASDAQ:GERN) between June 7, 2024 and February 25, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Read More
image for news ROSEN, A LEADING LAW FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN
Class Action Filed Against Geron Corporation (GERN) - May 12, 2025 Deadline to Join - Contact Levi & Korsinsky
GERN
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=136897&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against Geron Corporation (GERN) - May 12, 2025 Deadline to Join - Contact Levi & Korsinsky
Levi & Korsinsky Notifies Shareholders of Geron Corporation (GERN) of a Class Action Lawsuit and an Upcoming Deadline
GERN
Published: March 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit.

Read More
image for news Levi & Korsinsky Notifies Shareholders of Geron Corporation (GERN) of a Class Action Lawsuit and an Upcoming Deadline
Geron Corporation Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before May 12, 2025 to Discuss Your Rights – GERN
GERN
Published: March 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Geron Corporation (NASDAQ: GERN).

Read More
image for news Geron Corporation Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before May 12, 2025 to Discuss Your Rights – GERN
Levi & Korsinsky Reminds Geron Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN
GERN
Published: March 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=136650&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Geron Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN
Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation (GERN)
GERN
Published: March 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=136610&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation (GERN)
Geron Corporation Class Action: Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 – GERN
GERN
Published: March 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 14, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=136146&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Geron Corporation Class Action: Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 – GERN
Investors in Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN
GERN
Published: March 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 14, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=136094&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Investors in Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Geron Corporation (GERN) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
GERN
Published: March 14, 2025 by: GlobeNewsWire
Sentiment: Neutral

ATLANTA, March 14, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN). The lawsuit alleges that Defendants disseminated materially false and misleading statements and/or concealed material adverse facts concerning Rytelo's (imetelstat) potential.

Read More
image for news INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Geron Corporation (GERN) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Geron Corporation Securities and Sets a Lead Plaintiff Deadline of May 12, 2025
GERN
Published: March 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) between June 7, 2024 to February 25, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Reza Dabestani v.

Read More
image for news SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Geron Corporation Securities and Sets a Lead Plaintiff Deadline of May 12, 2025
Levi & Korsinsky Announces an Investigation on Behalf of Geron Corporation (GERN) Shareholders Who May Have Been Affected by Fraud
GERN
Published: March 11, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Geron Corporation ("Geron Corporation") (NASDAQ:GERN) concerning possible violations of federal securities laws. Geron announced its financial results for the fourth quarter and full year 2024 on February 26, 2025.

Read More
image for news Levi & Korsinsky Announces an Investigation on Behalf of Geron Corporation (GERN) Shareholders Who May Have Been Affected by Fraud
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
GERN
Published: March 11, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
ATTENTION Geron Corporation Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
GERN
Published: March 07, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Geron Corporation ("Geron Corporation") (NASDAQ:GERN) concerning possible violations of federal securities laws. Geron announced its financial results for the fourth quarter and full year 2024 on February 26, 2025.

Read More
image for news ATTENTION Geron Corporation Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
GERN
Published: March 07, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NASDAQ:GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
ATTENTION Geron Corporation Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
GERN
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Geron Corporation ("Geron Corporation") (NASDAQ:GERN) concerning possible violations of federal securities laws. Geron announced its financial results for the fourth quarter and full year 2024 on February 26, 2025.

Read More
image for news ATTENTION Geron Corporation Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
GERN
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NASDAQ:GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Kirby McInerney LLP Announces Investigation Against Geron Corporation (GERN) on Behalf of Investors
GERN
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Geron Corporation (“Geron” or the “Company”) (NASDAQ:GERN). The investigation concerns whether Geron and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

Read More
image for news Kirby McInerney LLP Announces Investigation Against Geron Corporation (GERN) on Behalf of Investors
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
GERN
Published: February 26, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , Feb. 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Geron Corporation (GERN) Q4 2024 Earnings Call Transcript
GERN
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral

Geron Corporation (NASDAQ:GERN ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Aron Feingold - VP of IR and Corporate Communications John Scarlett - Chairman and CEO Michelle Robertson - EVP and CFO Jim Ziegler - EVP and CCO Joseph Eid - EVP, R&D Faye Feller - EVP and CMO Conference Call Participants Peter Lawson - Barclays Tara Bancroft - TD Cowen Faisal Khurshid - Leerink Partners Greg Harrison - Scotiabank Stephen Willey - Stifel Emily Bodnar - H.C. Wainwright Kalpit Patel - B.

Read More
image for news Geron Corporation (GERN) Q4 2024 Earnings Call Transcript
3 Biotech/Healthcare Names Under $10 I Am Buying Now
ARDX, GERN, MRNA, PSNL, TEM
Published: February 21, 2025 by: Seeking Alpha
Sentiment: Positive

Today, I am highlighting three biotech/healthcare stocks that currently trade under $10 a share after some recent weakness. ! am slowly accumulating each of these names on these dips both straight equity purchases and covered call orders. All have had some recent positive despite the action in the shares and have good longer-term prospects.

Read More
image for news 3 Biotech/Healthcare Names Under $10 I Am Buying Now

About Geron Corporation (GERN)

  • IPO Date 1996-07-31
  • Website https://www.geron.com
  • Industry Biotechnology
  • CEO Ms. Dawn Carter Bir
  • Employees 229

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.